Tag: Capsule cross-linking

Complexity in Developing Modified-Release Capsules Overcoming the Complexity in Developing Modified-Release Capsules Context Developing modified-release capsules presents significant challenges in pharmaceutical formulation due to the need for precise control over the release rate of the active pharmaceutical ingredient (API). Modified-release capsules are designed to release their contents in a controlled, delayed, or sustained manner, rather…

Read More “Complexity in Developing Modified-Release Capsules” »

Difficulty in Masking the Bitter Taste of Certain Drugs Overcoming the Challenge of Masking the Bitter Taste of Certain Drugs in Capsules Context Bitter-tasting active pharmaceutical ingredients (APIs) present a significant challenge in capsule formulation, especially for oral dosage forms. Many patients, particularly pediatric or geriatric populations, struggle with swallowing pills that have an unpleasant…

Read More “Difficulty in Masking the Bitter Taste of Certain Drugs” »

Limitations in Using Water-Sensitive APIs in Soft Gelatin Capsules Addressing the Limitations of Using Water-Sensitive APIs in Soft Gelatin Capsules Context Water-sensitive active pharmaceutical ingredients (APIs) pose significant challenges in soft gelatin capsule formulations. The hydrophilic nature of gelatin capsules makes them inherently sensitive to moisture, which can interact with water-sensitive APIs, leading to degradation,…

Read More “Limitations in Using Water-Sensitive APIs in Soft Gelatin Capsules” »

High Risk of Cross-Linking Reactions Between Gelatin and Aldehyde-Containing Drugs Addressing the High Risk of Cross-Linking Reactions Between Gelatin and Aldehyde-Containing Drugs in Capsule Formulations Context Cross-linking reactions between gelatin and aldehyde-containing drugs present a significant challenge in soft gelatin capsule formulations. Gelatin, as a natural polymer, contains amino acids with functional groups that can…

Read More “High Risk of Cross-Linking Reactions Between Gelatin and Aldehyde-Containing Drugs” »

Requirement for Specialized Coating to Prevent Gastric Degradation Addressing the Requirement for Specialized Coating to Prevent Gastric Degradation of Drugs in Capsule Formulations Context Some drugs are susceptible to degradation in the acidic environment of the stomach, which can result in reduced efficacy or harmful byproducts. To prevent gastric degradation, specialized coatings are required for…

Read More “Requirement for Specialized Coating to Prevent Gastric Degradation” »

Uneven Distribution of Low-Dose Drugs in the Powder Blend Addressing the Issue of Uneven Distribution of Low-Dose Drugs in the Powder Blend for Capsule Formulations Context Uneven distribution of low-dose drugs in powder blends is a common challenge faced during the formulation of capsule dosage forms. Achieving a uniform blend of the active pharmaceutical ingredient…

Read More “Uneven Distribution of Low-Dose Drugs in the Powder Blend” »

Development Challenges for Fixed-Dose Combination Products Overcoming the Development Challenges for Fixed-Dose Combination Products in Capsules Context Fixed-dose combination (FDC) products are commonly used in pharmaceutical formulations to improve patient adherence and optimize therapeutic outcomes. However, developing these products, especially in capsule form, presents unique challenges. FDCs involve combining two or more active pharmaceutical ingredients…

Read More “Development Challenges for Fixed-Dose Combination Products” »

Problems with Low Drug Loading in Soft Gelatin Capsules Addressing the Challenges of Low Drug Loading in Soft Gelatin Capsules Context Low drug loading in soft gelatin capsules is a significant challenge in pharmaceutical formulation, especially when working with drugs that require high precision in dosage. Low drug loading refers to the inability to incorporate…

Read More “Problems with Low Drug Loading in Soft Gelatin Capsules” »

Difficulty in Formulating High-Dose Drugs into Capsule Dosage Forms Overcoming the Challenges in Formulating High-Dose Drugs into Capsule Dosage Forms Context Formulating high-dose drugs into capsule dosage forms presents a significant challenge in the pharmaceutical industry. High-dose drugs require a large volume of excipients to achieve the desired dose, and fitting such a large amount…

Read More “Difficulty in Formulating High-Dose Drugs into Capsule Dosage Forms” »

Issues with Compatibility Between Fillers and Active Ingredients Addressing Compatibility Issues Between Fillers and Active Ingredients in Capsule Formulations Context Compatibility between fillers (excipients) and active pharmaceutical ingredients (APIs) is a crucial consideration in the formulation of capsules. Incompatible fillers can lead to various problems, including reduced drug stability, inconsistent drug release, or even degradation…

Read More “Issues with Compatibility Between Fillers and Active Ingredients” »

Limited Formulation Options for Drugs with Extreme pH Sensitivity Addressing Limited Formulation Options for Drugs with Extreme pH Sensitivity in Capsules Context Drugs with extreme pH sensitivity pose significant challenges in capsule formulation. The solubility, stability, and bioavailability of such drugs are highly dependent on the pH of the gastrointestinal (GI) tract. The acidic environment…

Read More “Limited Formulation Options for Drugs with Extreme pH Sensitivity” »

Challenges in Achieving the Desired Dissolution Profile for Poorly Soluble Drugs Overcoming the Challenges in Achieving the Desired Dissolution Profile for Poorly Soluble Drugs in Capsule Formulations Context Achieving the desired dissolution profile for poorly soluble drugs is a significant challenge in the development of capsule formulations. Poor solubility can lead to reduced bioavailability, inconsistent…

Read More “Challenges in Achieving the Desired Dissolution Profile for Poorly Soluble Drugs” »